Pharma Mirror Magazine

Trailblazing Healthcare Sales Agent, Sarin, is Awarded iDE’s “40 Under 40” for Her Impact in Rural Bangladesh

June 16, 2023

Sarin Akter, a dynamic healthcare sales agent from Moulavibazar, Bangladesh, has been recently honored with iDE’s esteemed “40 Under 40”

Pharmaceutical Articles

Unveiling the Future: Key Trends in Clinical Trial Technology

June 16, 2023

In recent years, the field of clinical trials has witnessed a significant transformation due to advancements in technology. The integration

Pharmaceutical Articles

Meeting Global Demands for Viral Vector-based Vaccines

May 31, 2023

In the face of increasing global health challenges, the development and production of vaccines have become paramount. One critical aspect

Pharmaceutical News

Croda and Botanical Solution Inc. (BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production

May 24, 2023

Davis, California – Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the

Pharmaceutical Articles

Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry

May 11, 2023

Unlike compressor-based systems and cryovats, liquid nitrogen freezers safely deliver temperature-controlled freezing down to -160°C in minutes to preserve drug

Pharmaceutical News

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases

MORE NEWS

Trailblazing Healthcare Sales Agent, Sarin, is Awarded iDE’s “40 Under 40” for Her Impact in Rural Bangladesh

Unveiling the Future: Key Trends in Clinical Trial Technology

Meeting Global Demands for Viral Vector-based Vaccines

Croda and Botanical Solution Inc. (BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production

Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry

Breye Therapeutics Strengthens Management Team and Board